The Pros and Cons of Helicobacter pylori Treatment: A Focus on Cardiovascular Mortality

참고문헌 (8)

1. Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals : systematic review and meta-analysis of randomised controlled trials", BMJ, 348, pp.g3174~ (2014)
2. Choi IJ, "Helicobacter pylori therapy for the prevention of metachronous gastric cancer", N Engl J Med, 378, pp.1085~1095 (2018)
3. Wong AY, "Cardiovascular outcomes associated with use of clarithromycin : population based study", BMJ, 352, pp.h6926~ (2016)
4. Root AA, "Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs", Br J Clin Pharmacol, 82, pp.512~521 (2016)
5. Andersen SS, "Clarithromycin use and risk of death in patients with ischemic heart disease", Cardiology, 116, pp.89~97 (2010)
6. Boursi B, "Recurrent antibiotic exposure may promote cancer formation: another step in understanding the role of the human microbiota?", Eur J Cancer, 51, pp.2655~2664 (2015)
7. Young-Il Kim, "Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension", Gut and Liver, 14(1), pp.47~56 (2020), 거트앤리버 소화기연관학회협의회
8. Mosholder AD, "Long-term risk of acute myocardial infarction, stroke, and death with outpatient use of clarithromycin : a retrospective cohort study", Am J Epidemiol, 187, pp.786~792 (2018)

관련 논문AI추천